(WMS) Advanced Drainage Systems - Overview
Sector: Industrials | Industry: Building Products & Equipment | Exchange: NYSE (USA) | Market Cap: 10.885m USD | Total Return: 14.3% in 12m
Industry Rotation: -14.5
Avg Turnover: 98.0M
EPS Trend: -38.8%
Qual. Beats: -1
Rev. Trend: -4.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Advanced Drainage Systems, Inc. (WMS) is a leading provider of water management solutions, specializing in the manufacture of thermoplastic corrugated pipes and related infrastructure components. The company operates through four primary segments: Pipe, Infiltrator, International, and Allied Products, serving residential, non-residential, agricultural, and infrastructure markets. Its product portfolio includes high-density polyethylene (HDPE) and polypropylene pipes, septic systems, wastewater treatment solutions, and geosynthetic fabrics used for soil stabilization and erosion control.
The business model relies on a vast distribution network to deliver bulky, high-performance plastic alternatives to traditional materials like concrete or steel. Within the building products sector, the shift toward thermoplastic materials is driven by their lower installation costs, corrosion resistance, and lighter weight compared to legacy infrastructure materials. As environmental regulations tighten, the demand for sophisticated stormwater management and subsurface drainage systems continues to grow across North American construction projects.
Investors can evaluate the company’s valuation metrics and historical performance trends by exploring the tools available on ValueRay.
- Residential and non-residential construction starts drive demand for thermoplastic piping systems
- Fluctuations in high-density polyethylene and polypropylene resin costs impact gross margins
- Federal infrastructure spending and environmental regulations accelerate storm water management adoption
- Material conversion from traditional concrete and metal to lightweight polymer solutions
- Residential septic market cycles influence Infiltrator segment revenue and profitability margins
| Net Income: 470.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 4.37 > 1.0 |
| NWC/Revenue: 43.21% < 20% (prev 29.13%; Δ 14.08% < -1%) |
| CFO/TA 0.20 > 3% & CFO 820.4m > Net Income 470.7m |
| Net Debt (437.5m) to EBITDA (895.1m): 0.49 < 3 |
| Current Ratio: 4.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.3m) vs 12m ago 0.28% < -2% |
| Gross Margin: 38.22% > 18% (prev 0.38%; Δ 3.78k% > 0.5%) |
| Asset Turnover: 77.18% > 50% (prev 81.68%; Δ -4.50% > 0%) |
| Interest Coverage Ratio: 7.75 > 6 (EBITDA TTM 895.1m / Interest Expense TTM 91.5m) |
| A: 0.31 (Total Current Assets 1.71b - Total Current Liabilities 413.4m) / Total Assets 4.14b |
| B: 0.44 (Retained Earnings 1.84b / Total Assets 4.14b) |
| C: 0.18 (EBIT TTM 709.1m / Avg Total Assets 3.87b) |
| D: 0.86 (Book Value of Equity 1.83b / Total Liabilities 2.12b) |
| Altman-Z'' Score: 5.63 = AAA |
| DSRI: 0.94 (Receivables 237.6m/247.9m, Revenue 2.99b/2.94b) |
| GMI: 1.00 (GM 38.22% / 38.06%) |
| AQI: 0.83 (AQ_t 0.31 / AQ_t-1 0.37) |
| SGI: 1.02 (Revenue 2.99b / 2.94b) |
| TATA: -0.08 (NI 470.7m - CFO 820.4m) / TA 4.14b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
Over the past week, the price has changed by -5.28%, over one month by -11.56%, over three months by -20.49% and over the past year by +14.28%.
- StrongBuy: 7
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 189.2 | 39.5% |
P/E Forward = 20.9644
P/S = 3.6413
P/B = 5.5591
P/EG = 1.2342
Revenue TTM = 2.99b USD
EBIT TTM = 709.1m USD
EBITDA TTM = 895.1m USD
Long Term Debt = 1.28b USD (from longTermDebt, last quarter)
Short Term Debt = 43.1m USD (from shortTermDebt, last quarter)
Debt = 1.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 437.5m USD (from netDebt column, last quarter)
Enterprise Value = 11.32b USD (10.89b + Debt 1.45b - CCE 1.01b)
Interest Coverage Ratio = 7.75 (Ebit TTM 709.1m / Interest Expense TTM 91.5m)
EV/FCF = 19.62x (Enterprise Value 11.32b / FCF TTM 577.1m)
FCF Yield = 5.10% (FCF TTM 577.1m / Enterprise Value 11.32b)
FCF Margin = 19.30% (FCF TTM 577.1m / Revenue TTM 2.99b)
Net Margin = 15.75% (Net Income TTM 470.7m / Revenue TTM 2.99b)
Gross Margin = 38.22% ((Revenue TTM 2.99b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 35.43% (prev 40.00%)
Tobins Q-Ratio = 2.73 (Enterprise Value 11.32b / Total Assets 4.14b)
Interest Expense / Debt = 1.56% (Interest Expense 22.6m / Debt 1.45b)
Taxrate = 24.53% (30.6m / 124.6m)
NOPAT = 535.2m (EBIT 709.1m * (1 - 24.53%))
Current Ratio = 4.12 (Total Current Assets 1.71b / Total Current Liabilities 413.4m)
Debt / Equity = 0.72 (Debt 1.45b / totalStockholderEquity, last quarter 2.01b)
Debt / EBITDA = 0.49 (Net Debt 437.5m / EBITDA 895.1m)
Debt / FCF = 0.76 (Net Debt 437.5m / FCF TTM 577.1m)
Total Stockholder Equity = 1.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.15% (Net Income 470.7m / Total Assets 4.14b)
RoE = 25.82% (Net Income TTM 470.7m / Total Stockholder Equity 1.82b)
RoCE = 22.88% (EBIT 709.1m / Capital Employed (Equity 1.82b + L.T.Debt 1.28b))
RoIC = 17.33% (NOPAT 535.2m / Invested Capital 3.09b)
WACC = 10.15% (E(10.89b)/V(12.33b) * Re(11.34%) + D(1.45b)/V(12.33b) * Rd(1.56%) * (1-Tc(0.25)))
Discount Rate = 11.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.46 | Cagr: -0.55%
[DCF] Terminal Value 71.24% ; FCFF base≈483.9m ; Y1≈491.4m ; Y5≈537.6m
[DCF] Fair Price = 80.46 (EV 6.71b - Net Debt 437.5m = Equity 6.27b / Shares 77.9m; r=10.15% [WACC]; 5y FCF grow 1.26% → 3.0% )
EPS Correlation: -38.84 | EPS CAGR: -51.94% | SUE: -4.0 | # QB: -1
Revenue Correlation: -4.82 | Revenue CAGR: 0.59% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.10 | Chg30d=-1.29% | Revisions=-33% | Analysts=5
[Analyst] Revisions Ratio: -33%